Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.

Lima M, Almeida J, Montero AG, Teixeira Mdos A, Queirós ML, Santos AH, Balanzategui A, Estevinho A, Algueró Mdel C, Barcena P, Fonseca S, Amorim ML, Cabeda JM, Pinho L, Gonzalez M, San Miguel J, Justiça B, Orfão A.

Am J Pathol. 2004 Oct;165(4):1117-27.

2.

TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.

Lima M, Almeida J, Dos Anjos Teixeira M, Alguero Md Mdel C, Santos AH, Balanzategui A, Queirós ML, Bárcena P, Izarra A, Fonseca S, Bueno C, Justiça B, Gonzalez M, San Miguel JF, Orfao A.

Am J Pathol. 2003 Aug;163(2):763-71.

3.

The "ex vivo" patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/late NK-cell activation states.

Lima M, Almeida J, dos Anjos Teixeira M, Queirós ML, Justiça B, Orfão A.

Blood Cells Mol Dis. 2002 Mar-Apr;28(2):181-90.

PMID:
12064914
4.

Clinicopathological and phenotypic features of chronic NK cell lymphocytosis identified among patients with asymptomatic lymphocytosis.

Cao F, Zhao H, Li Y, Dai S, Wang C.

Int J Lab Hematol. 2015 Dec;37(6):783-90. doi: 10.1111/ijlh.12410. Epub 2015 Jul 31.

PMID:
26234181
7.

Immunophenotype and TCR-Vbeta repertoire of peripheral blood T-cells in acute infectious mononucleosis.

Lima M, Teixeira Mdos A, Queirós ML, Santos AH, Gonçalves C, Correia J, Farinha F, Mendonça F, Soares JM, Almeida J, Orfão A, Justiça B.

Blood Cells Mol Dis. 2003 Jan-Feb;30(1):1-12.

PMID:
12667982
8.
9.

Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.

Domaica CI, Fuertes MB, Uriarte I, Girart MV, Sardañons J, Comas DI, Di Giovanni D, Gaillard MI, Bezrodnik L, Zwirner NW.

PLoS One. 2012;7(12):e51677. doi: 10.1371/journal.pone.0051677. Epub 2012 Dec 11.

10.

Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties.

Lima M, Teixeira MA, Queirós ML, Leite M, Santos AH, Justiça B, Orfão A.

Blood Cells Mol Dis. 2001 Jul-Aug;27(4):731-43.

PMID:
11778657
11.

Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.

Ghosh S, Nandi M, Pal S, Mukhopadhyay D, Chakraborty BC, Khatun M, Bhowmick D, Mondal RK, Das S, Das K, Ghosh R, Banerjee S, Santra A, Chatterjee M, Chowdhury A, Datta S.

Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.

PMID:
27208430
12.

Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.

Miyagi T, Shimizu S, Tatsumi T, Nishio K, Hiramatsu N, Kanto T, Hayashi N, Takehara T.

J Gastroenterol. 2011 Aug;46(8):1020-30. doi: 10.1007/s00535-011-0408-8. Epub 2011 May 11.

PMID:
21559771
13.

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA.

Blood. 2010 Jan 14;115(2):274-81. doi: 10.1182/blood-2009-04-215491. Epub 2009 Nov 6.

14.

The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.

Braun M, Müller B, ter Meer D, Raffegerst S, Simm B, Wilde S, Spranger S, Ellwart J, Mosetter B, Umansky L, Lerchl T, Schendel DJ, Falk CS.

J Innate Immun. 2011;3(4):420-34. doi: 10.1159/000322720. Epub 2010 Dec 18.

PMID:
21178331
15.

Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.

Lima JF, Oliveira LM, Pereira NZ, Mitsunari GE, Duarte AJ, Sato MN.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):463-71. doi: 10.1097/QAI.0000000000000350.

PMID:
25230289
16.

[Human peripheral blood CD56+ natural killer cell subsets and their phenotypic and biological properties].

Wu CY, Liu J, Yang BY, Roedere M.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):169-72. Chinese.

PMID:
16875598
17.

Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.

Tarazona R, Casado JG, Delarosa O, Torre-Cisneros J, Villanueva JL, Sanchez B, Galiani MD, Gonzalez R, Solana R, Peña J.

J Clin Immunol. 2002 May;22(3):176-83.

PMID:
12078859
18.

Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.

Lutz CT, Karapetyan A, Al-Attar A, Shelton BJ, Holt KJ, Tucker JH, Presnell SR.

J Immunol. 2011 Apr 15;186(8):4590-8. doi: 10.4049/jimmunol.1002732. Epub 2011 Mar 14.

19.

[Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].

Li ZS, Shao ZH, Fu R, Wang J, Li LJ, Zhang T, Wang HQ, Wu YH, Ruan EB, Song J, Qu W, Liu H, Xing LM, Wang XM, Liang Y, Guan J, Wang GJ.

Zhonghua Yi Xue Za Zhi. 2011 Apr 26;91(16):1084-7. Chinese.

PMID:
21609587
20.

Phenotypic heterogeneity of persistent expansions of CD4+ CD8+ T cells.

Tonutti E, Sala P, Feruglio C, Yin Z, Colombatti A.

Clin Immunol Immunopathol. 1994 Dec;73(3):312-20.

PMID:
7955559

Supplemental Content

Support Center